These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 12824704)
1. Random analysis of amino acid pairs sensitive to variants in human coagulation factor IX precursor. Wu G; Yan S J Biomed Sci; 2003; 10(4):451-4. PubMed ID: 12824704 [TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of a cDNA coding for human factor IX. Kurachi K; Davie EW Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6461-4. PubMed ID: 6959130 [TBL] [Abstract][Full Text] [Related]
3. Determination of amino acid pairs sensitive to variants in human low-density lipoprotein receptor precursor by means of a random approach. Wu G; Yan S J Biochem Mol Biol Biophys; 2002 Dec; 6(6):401-6. PubMed ID: 14972795 [TBL] [Abstract][Full Text] [Related]
4. Amino acid pairs susceptible to variants in human protein C precursor. Wu G; Yan S Protein Pept Lett; 2005 Jul; 12(5):491-4. PubMed ID: 16029164 [TBL] [Abstract][Full Text] [Related]
5. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients. Furutani H Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581 [TBL] [Abstract][Full Text] [Related]
6. Analysis of amino acid pairs sensitive to variants in human collagen alpha5(IV) chain precursor by means of a random approach. Wu G; Yan S Peptides; 2003 Mar; 24(3):347-52. PubMed ID: 12732331 [TBL] [Abstract][Full Text] [Related]
7. Warfarin treatment of a patient with coagulation factor IX propeptide mutation causing warfarin hypersensitivity. Kristensen SR Blood; 2002 Oct; 100(7):2676-7. PubMed ID: 12360981 [No Abstract] [Full Text] [Related]
8. Determination of amino acid pairs in human p53 protein sensitive to mutations/variants by means of a random approach. Wu G; Yan S J Mol Model; 2003 Oct; 9(5):337-41. PubMed ID: 14517612 [TBL] [Abstract][Full Text] [Related]
9. Determination of amino acid pairs sensitive to variants in human beta-glucocerebrosidase by means of a random approach. Wu G; Yan S Protein Eng; 2003 Mar; 16(3):195-9. PubMed ID: 12702799 [TBL] [Abstract][Full Text] [Related]
10. Structure and function of factor IX: defects in haemophilia B. McGraw RA; Davis LM; Lundblad RL; Stafford DW; Roberts HR Clin Haematol; 1985 Jun; 14(2):359-83. PubMed ID: 3899439 [TBL] [Abstract][Full Text] [Related]
11. Estimation of amino acid pairs sensitive to variants in human phenylalanine hydroxylase protein by means of a random approach. Wu G; Yan S Peptides; 2002 Dec; 23(12):2085-90. PubMed ID: 12535686 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. McGraw RA; Davis LM; Noyes CM; Lundblad RL; Roberts HR; Graham JB; Stafford DW Proc Natl Acad Sci U S A; 1985 May; 82(9):2847-51. PubMed ID: 3857619 [TBL] [Abstract][Full Text] [Related]
13. Role of the propeptide and gamma-glutamic acid domain of factor IX for in vitro carboxylation by the vitamin K-dependent carboxylase. Stanley TB; Wu SM; Houben RJ; Mutucumarana VP; Stafford DW Biochemistry; 1998 Sep; 37(38):13262-8. PubMed ID: 9748333 [TBL] [Abstract][Full Text] [Related]
14. Factor IX gene analysis in 70 unrelated patients with haemophilia B: description of 13 new mutations. Attali O; Vinciguerra C; Trzeciak MC; Durin A; Pernod G; Gay V; Ménart C; Sobas F; Dechavanne M; Négrier C Thromb Haemost; 1999 Nov; 82(5):1437-42. PubMed ID: 10595634 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the mutations causing hemophilia B in 2 domestic cats. Goree M; Catalfamo JL; Aber S; Boudreaux MK J Vet Intern Med; 2005; 19(2):200-4. PubMed ID: 15822564 [TBL] [Abstract][Full Text] [Related]
16. Sequence and structural properties of identical mutations with varying phenotypes in human coagulation factor IX. Chavali S; Sharma A; Tabassum R; Bharadwaj D Proteins; 2008 Oct; 73(1):63-71. PubMed ID: 18393396 [TBL] [Abstract][Full Text] [Related]
17. Effects of codon optimization on coagulation factor IX translation and structure: Implications for protein and gene therapies. Alexaki A; Hettiarachchi GK; Athey JC; Katneni UK; Simhadri V; Hamasaki-Katagiri N; Nanavaty P; Lin B; Takeda K; Freedberg D; Monroe D; McGill JR; Peters R; Kames JM; Holcomb DD; Hunt RC; Sauna ZE; Gelinas A; Janjic N; DiCuccio M; Bar H; Komar AA; Kimchi-Sarfaty C Sci Rep; 2019 Oct; 9(1):15449. PubMed ID: 31664102 [TBL] [Abstract][Full Text] [Related]
18. Molecular basis of hemophilia B: a defective enzyme due to an unprocessed propeptide is caused by a point mutation in the factor IX precursor. Diuguid DL; Rabiet MJ; Furie BC; Liebman HA; Furie B Proc Natl Acad Sci U S A; 1986 Aug; 83(16):5803-7. PubMed ID: 3461460 [TBL] [Abstract][Full Text] [Related]
19. Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity. Branchini A; Campioni M; Mazzucconi MG; Biondo F; Mari R; Bicocchi MP; Bernardi F; Pinotti M FEBS Lett; 2013 Oct; 587(19):3249-53. PubMed ID: 23994528 [TBL] [Abstract][Full Text] [Related]
20. Structure and evolution of the human genes encoding protein C and coagulation factor IX. Long GL J Cell Biochem; 1987 Mar; 33(3):185-90. PubMed ID: 3571341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]